Compare Domino's Pizza, Inc. (DPZ) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Domino's Pizza, Inc. vs GeneDx Holdings Corp — how do they compare? Domino's Pizza, Inc. trades at $309.36 (market cap $10.21B), while GeneDx Holdings Corp trades at $67.33 (market cap $2.02B). The key difference: Domino's Pizza, Inc. is far larger — about 5.1× GeneDx Holdings Corp's market cap, and Domino's Pizza, Inc. pays a 2.58% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Domino's Pizza, Inc. for 106 Days and GeneDx Holdings Corp for 19 Days on average.
| DPZ | WGS | |
|---|---|---|
Market Cap | $10.21B | $2.02B |
Volume | 916,737 | 734,640 |
Sector | Consumer Cyclical | Health |
52-Week High | $438.42 | $167.51 |
52-Week Low | $282.89 | $34.51 |
Typical Hold Time | 106 Days | 19 Days |
Enterprise Value | $15.17B | $2.05B |
Dividend Yield | 2.58% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DPZ trades at $308.65, up 1.83% today, with a bullish technical signal but recent earnings misses. Revenue grew to $4.94B in 2025 with a net income margin of 11.86%, though the company carries significant debt. Analyst consensus is a Buy with a $373 price target, but news highlights concerns over dividend growth and store closures.
The outlook is mixed: strong profitability and analyst support suggest upside, but high debt and recent underperformance pose risks. Investors should weigh solid fundamentals against execution challenges and macroeconomic pressures on the restaurant sector.
GeneDx (WGS) trades at $67.73, down 1.17% with bearish technical signals despite recent earnings beats. The company shows strong revenue growth to $454M in 2026 but faces profitability challenges with a -23.4% net margin. Recent developments include new genomic testing products and hospital partnerships, while analyst consensus remains strongly bullish with a $81 price target.
The stock presents a growth story with expanding genomic testing volumes but carries significant execution risk given negative profitability metrics. Upside potential exists if management can translate revenue growth into sustainable profits, though current cash flow trends and high valuation multiples warrant caution for risk-averse investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Domino's Pizza, Inc.
Domino's is a restaurant operator and franchiser with nearly 19,000 global stores across more than 90 international markets at the end of 2021. The firm generates revenue through the sales of pizza, wings, salads, and sandwiches at company-owned stores, royalty and marketing contributions from franchise-operated stores, and its network of 25 domestic (and five Canadian) dough manufacturing and supply chain facilities, which centralize purchasing, preparation, and last-mile delivery for the firm's U.S. and Canadian restaurants. With roughly $17.7 billion in 2021 system sales, Domino's is the largest player in the global pizza market, ahead of Pizza Hut, Papa John's, and Little Caesars.
Read more on DPZ →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
